HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer

Overview

Journal Clin Cancer Res

Specialty Oncology

Date 2013 Nov 19

PMID 24240108

Citations 45

Authors

Vikas Sehdev

Ahmed Katsha

Janet Arras

Dunfa Peng

Mohammed Soutto

Jeffrey Ecsedy

Alexander Zaika

Abbes Belkhiri

Wael El-Rifai

Affiliations

Soon will be listed here.

Abstract

Purpose: Suppression of P53 (tumor protein 53) transcriptional function mediates poor therapeutic response in patients with cancer. Aurora kinase A (AURKA) and human double minute 2 (HDM2) are negative regulators of P53. Herein, we examined the role of AURKA in regulating HDM2 and its subsequent effects on P53 apoptotic function in gastric cancer.

Experimental Design: Primary tumors and in vitro gastric cancer cell models with overexpression or knockdown of AURKA were used. The role of AURKA in regulating HDM2 and cell survival coupled with P53 expression and activity were investigated.

Results: Overexpression of AURKA enhanced the HDM2 protein level; conversely, knockdown of endogenous AURKA decreased expression of HDM2 in AGS and SNU-1 cells. Dual co-immunoprecipitation assay data indicated that AURKA was associated with HDM2 in a protein complex. The in vitro kinase assay using recombinant AURKA and HDM2 proteins followed by co-immunoprecipitation revealed that AURKA directly interacts and phosphorylates HDM2 protein in vitro. The activation of HDM2 by AURKA led to induction of P53 ubiquitination and attenuation of cisplatin-induced activation of P53 in gastric cancer cells. Inhibition of AURKA using an investigational small-molecule specific inhibitor, alisertib, decreased the HDM2 protein level and induced P53 transcriptional activity. These effects markedly decreased cell survival in vitro and xenograft tumor growth in vivo. Notably, analysis of immunohistochemistry on tissue microarrays revealed significant overexpression of AURKA and HDM2 in human gastric cancer samples (P < 0.05).

Conclusion: Collectively, our novel findings indicate that AURKA promotes tumor growth and cell survival through regulation of HDM2-induced ubiquitination and inhibition of P53. Clin Cancer Res; 20(1); 76-86. ©2013 AACR.

Citing Articles

NKX6.3 modulation of mitotic dynamics and genomic stability in gastric carcinogenesis.

Yoon J, Kim J, Eun J, Ashktorab H, Smoot D, Nam S Cell Commun Signal. 2025; 23(1):35.

PMID: 39833908 PMC: 11748348. DOI: 10.1186/s12964-025-02030-4.

SOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation.

Gomaa A, Maacha S, Peng D, Soutto M, Genoula M, Bhat N Cancer Lett. 2024; 593():216939.

PMID: 38729556 PMC: 11175609. DOI: 10.1016/j.canlet.2024.216939.

AURKA inhibition induces Ewing's sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis.

Chen H, Hu J, Xiong X, Chen H, Lin B, Chen Y Cell Death Dis. 2024; 15(1):99.

PMID: 38287009 PMC: 10825207. DOI: 10.1038/s41419-024-06485-0.

Digging out the biology properties of tRNA-derived small RNA from black hole.

Shi H, Xie J, Pei S, He D, Hou H, Xu S Front Genet. 2023; 14:1232325.

PMID: 37953919 PMC: 10637384. DOI: 10.3389/fgene.2023.1232325.

Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases.

Kumari P, Beeraka N, Tengli A, Bannimath G, Baath R, Patil M Curr Med Chem. 2023; 31(23):3502-3528.

PMID: 37138483 DOI: 10.2174/0929867330666230503124408.

References

Dar A, Belkhiri A, El-Rifai W . The aurora kinase A regulates GSK-3beta in gastric cancer cells. Oncogene. 2008; 28(6):866-75. PMC: 2642527. DOI: 10.1038/onc.2008.434. View

Rugge M, Fassan M, Zaninotto G, Pizzi M, Giacomelli L, Battaglia G . Aurora kinase A in Barrett's carcinogenesis. Hum Pathol. 2010; 41(10):1380-6. DOI: 10.1016/j.humpath.2010.02.016. View

Carmena M, Earnshaw W . The cellular geography of aurora kinases. Nat Rev Mol Cell Biol. 2003; 4(11):842-54. DOI: 10.1038/nrm1245. View

Howlader N, Ries L, Stinchcomb D, Edwards B . The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. J Natl Cancer Inst. 2009; 101(7):533-6. PMC: 2720708. DOI: 10.1093/jnci/djn517. View

Huang S, Chen M, Shen Y, Shen W, Guo H, Gao Q . Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. Cancer Lett. 2011; 315(2):198-205. DOI: 10.1016/j.canlet.2011.10.011. View

Schuster K, Fan L, Harris L . MDM2 splice variants predominantly localize to the nucleoplasm mediated by a COOH-terminal nuclear localization signal. Mol Cancer Res. 2007; 5(4):403-12. DOI: 10.1158/1541-7786.MCR-06-0146. View

Wang X, Zhou Y, Qiao W, Tominaga Y, Ouchi M, Ouchi T . Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene. 2006; 25(54):7148-58. DOI: 10.1038/sj.onc.1209707. View

Wade M, Wang Y, Wahl G . The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 2010; 20(5):299-309. PMC: 2910097. DOI: 10.1016/j.tcb.2010.01.009. View

Van Cutsem E, Van de Velde C, Roth A, Lordick F, Kohne C, Cascinu S . Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer. 2007; 44(2):182-94. DOI: 10.1016/j.ejca.2007.11.001. View

10.

Dar A, Goff L, Majid S, Berlin J, El-Rifai W . Aurora kinase inhibitors--rising stars in cancer therapeutics?. Mol Cancer Ther. 2010; 9(2):268-78. PMC: 2820587. DOI: 10.1158/1535-7163.MCT-09-0765. View

11.

Rayburn E, Zhang R, He J, Wang H . MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy. Curr Cancer Drug Targets. 2005; 5(1):27-41. DOI: 10.2174/1568009053332636. View

12.

Katayama H, Ota T, Jisaki F, Ueda Y, Tanaka T, ODASHIMA S . Mitotic kinase expression and colorectal cancer progression. J Natl Cancer Inst. 1999; 91(13):1160-2. DOI: 10.1093/jnci/91.13.1160. View

13.

Sumi K, Tago K, Kasahara T, Funakoshi-Tago M . Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cells. FEBS Lett. 2011; 585(12):1884-90. DOI: 10.1016/j.febslet.2011.04.068. View

14.

Anand S, Penrhyn-Lowe S, Venkitaraman A . AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell. 2003; 3(1):51-62. DOI: 10.1016/s1535-6108(02)00235-0. View

15.

Sehdev V, Peng D, Soutto M, Washington M, Revetta F, Ecsedy J . The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Mol Cancer Ther. 2012; 11(3):763-74. PMC: 3297687. DOI: 10.1158/1535-7163.MCT-11-0623. View

16.

Matuschek C, Bolke E, Peiper M, Knoefel W, Budach W, Erhardt A . The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract. Eur J Med Res. 2011; 16(6):265-74. PMC: 3353402. DOI: 10.1186/2047-783x-16-6-265. View

17.

Reim D, Gertler R, Novotny A, Becker K, Zum Buschenfelde C, Ebert M . Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer. Ann Surg Oncol. 2011; 19(7):2108-18. DOI: 10.1245/s10434-011-2147-8. View

18.

Belkhiri A, Zaika A, Pidkovka N, Knuutila S, Moskaluk C, El-Rifai W . Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas. Cancer Res. 2005; 65(15):6583-92. DOI: 10.1158/0008-5472.CAN-05-1433. View

19.

Fang Z, Xiong Y, Li J, Liu L, Li M, Zhang C . Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression. Med Oncol. 2010; 28(4):1017-22. DOI: 10.1007/s12032-010-9602-4. View

20.

Zhao L, Pan Y, Gang Y, Wang H, Jin H, Tie J . Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library. J Biol Chem. 2009; 284(39):26273-85. PMC: 2785315. DOI: 10.1074/jbc.M109.028068. View